Pfizer Raises Annual Profit Forecast After Better-Than-Expected COVID Sales

Reuters07-30

July 30 (Reuters) - U.S. drugmaker Pfizer raised its annual profit forecast on Tuesday after posting better-than-expected sales for its COVID vaccine and antiviral treatment.

New Jersey-based Pfizer now expects annual profit to be in the range of $2.45 to $2.65 per share, compared with its prior profit forecast of $2.15 to $2.35 per share.

With the pandemic becoming less severe, the market for pharmaceutical products used in managing COVID-19 has quickly disappeared, eroding billions of dollars in sales of vaccines and treatments for companies such as Pfizer.

Pfizer said it was now expecting full-year revenue of $8.5 billion from its Comirnaty and Paxlovid vaccines, up from its previous expectation of about $8 billion.

After the company's COVID windfall, Pfizer CEO Albert Bourla spent $43 billion to buy cancer drugmaker Seagen. The company has also cut costs and launched an internal restructuring to tighten its focus on cancer drugs.

Its shares have nearly halved since their pandemic-era highs. Shares rose 3.5% at $31.6 in premarket trading.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

BenjiFuji
07-31
BenjiFuji
Errata spotted. Pfizer is based in NYC, not New Jersy. [LOL]

Leave a comment

1

4

1

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1171080301?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-07-30 18:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1171080301","market":"us","top_or_hot":-1,"title":"Pfizer Raises Annual Profit Forecast After Better-Than-Expected COVID Sales","media":"Reuters","content":"<html><head></head><body><p>July 30 (Reuters) - U.S. drugmaker Pfizer raised its annual profit forecast on Tuesday after posting better-than-expected sales for its COVID vaccine and antiviral treatment.</p><p>New Jersey-based Pfizer now expects annual profit to be in the range of $2.45 to $2.65 per share, compared with its prior profit forecast of $2.15 to $2.35 per share.</p><p>With the pandemic becoming less severe, the market for pharmaceutical products used in managing COVID-19 has quickly disappeared, eroding billions of dollars in sales of vaccines and treatments for companies such as Pfizer.</p><p>Pfizer said it was now expecting full-year revenue of $8.5 billion from its Comirnaty and Paxlovid vaccines, up from its previous expectation of about $8 billion.</p><p>After the company&#39;s COVID windfall, Pfizer CEO Albert Bourla spent $43 billion to buy cancer drugmaker Seagen. The company has also cut costs and launched an internal restructuring to tighten its focus on cancer drugs.</p><p>Its shares have nearly halved since their pandemic-era highs. Shares rose 3.5% at $31.6 in premarket trading.</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Raises Annual Profit Forecast After Better-Than-Expected COVID Sales</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Raises Annual Profit Forecast After Better-Than-Expected COVID Sales\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-30 18:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4129958-pfizer-non-gaap-eps-of-0_60-beats-0_14-revenue-of-13_28b-beats-260m><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>July 30 (Reuters) - U.S. drugmaker Pfizer raised its annual profit forecast on Tuesday after posting better-than-expected sales for its COVID vaccine and antiviral treatment.New Jersey-based Pfizer ...</p>\n\n<a href=\"https://seekingalpha.com/news/4129958-pfizer-non-gaap-eps-of-0_60-beats-0_14-revenue-of-13_28b-beats-260m\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PFE","symbol_name":"辉瑞","start_time":0,"source_url":"https://seekingalpha.com/news/4129958-pfizer-non-gaap-eps-of-0_60-beats-0_14-revenue-of-13_28b-beats-260m","article_id":"1171080301","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1171080301","pubTimestamp":1722336609,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"July 30  - U.S. drugmaker Pfizer raised its annual profit forecast on Tuesday after posting better-than-expected sales for its COVID vaccine and antiviral treatment.New Jersey-based Pfizer now expects annual profit to be in the range of $2.45 to $2.65 per share, compared with its prior profit forecast of $2.15 to $2.35 per share.With the pandemic becoming less severe, the market for pharmaceutical products used in managing COVID-19 has quickly disappeared, eroding billions of dollars in sales of","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"PFE":"辉瑞"},"translate_title":"新冠疫情销售好于预期后辉瑞上调年度利润预期","themeId":"c0d77e622a6742cf8335299f8317b4b4","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PFE":1.1},"content_text":"July 30 (Reuters) - U.S. drugmaker Pfizer raised its annual profit forecast on Tuesday after posting better-than-expected sales for its COVID vaccine and antiviral treatment.New Jersey-based Pfizer now expects annual profit to be in the range of $2.45 to $2.65 per share, compared with its prior profit forecast of $2.15 to $2.35 per share.With the pandemic becoming less severe, the market for pharmaceutical products used in managing COVID-19 has quickly disappeared, eroding billions of dollars in sales of vaccines and treatments for companies such as Pfizer.Pfizer said it was now expecting full-year revenue of $8.5 billion from its Comirnaty and Paxlovid vaccines, up from its previous expectation of about $8 billion.After the company's COVID windfall, Pfizer CEO Albert Bourla spent $43 billion to buy cancer drugmaker Seagen. The company has also cut costs and launched an internal restructuring to tighten its focus on cancer drugs.Its shares have nearly halved since their pandemic-era highs. Shares rose 3.5% at $31.6 in premarket trading.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[{"id":333324559958088,"gmtCreate":1722406096564,"gmtModify":1722406104013,"author":{"id":"4110175785559852","authorId":"4110175785559852","name":"BenjiFuji","avatar":"https://community-static.tradeup.com/news/330f59d829009a2c318784ab2b5e6098","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":5,"crmLevelSwitch":0,"idStr":"4110175785559852","authorIdStr":"4110175785559852"},"htmlText":"Errata spotted. Pfizer is based in NYC, not New Jersy. [LOL]&nbsp;&nbsp;","listText":"Errata spotted. Pfizer is based in NYC, not New Jersy. [LOL]&nbsp;&nbsp;","text":"Errata spotted. Pfizer is based in NYC, not New Jersy. [LOL]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/333324559958088","repostId":1171080301,"repostType":2,"repost":{"id":"1171080301","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1722336609,"share":"https://ttm.financial/m/news/1171080301?lang=&edition=fundamental","pubTime":"2024-07-30 18:50","market":"us","language":"en","title":"Pfizer Raises Annual Profit Forecast After Better-Than-Expected COVID Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=1171080301","media":"Reuters","summary":"July 30  - U.S. drugmaker Pfizer raised its annual profit forecast on Tuesday after posting better-than-expected sales for its COVID vaccine and antiviral treatment.New Jersey-based Pfizer now expects annual profit to be in the range of $2.45 to $2.65 per share, compared with its prior profit forecast of $2.15 to $2.35 per share.With the pandemic becoming less severe, the market for pharmaceutical products used in managing COVID-19 has quickly disappeared, eroding billions of dollars in sales of","content":"<html><head></head><body><p>July 30 (Reuters) - U.S. drugmaker Pfizer raised its annual profit forecast on Tuesday after posting better-than-expected sales for its COVID vaccine and antiviral treatment.</p><p>New Jersey-based Pfizer now expects annual profit to be in the range of $2.45 to $2.65 per share, compared with its prior profit forecast of $2.15 to $2.35 per share.</p><p>With the pandemic becoming less severe, the market for pharmaceutical products used in managing COVID-19 has quickly disappeared, eroding billions of dollars in sales of vaccines and treatments for companies such as Pfizer.</p><p>Pfizer said it was now expecting full-year revenue of $8.5 billion from its Comirnaty and Paxlovid vaccines, up from its previous expectation of about $8 billion.</p><p>After the company&#39;s COVID windfall, Pfizer CEO Albert Bourla spent $43 billion to buy cancer drugmaker Seagen. The company has also cut costs and launched an internal restructuring to tighten its focus on cancer drugs.</p><p>Its shares have nearly halved since their pandemic-era highs. Shares rose 3.5% at $31.6 in premarket trading.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Raises Annual Profit Forecast After Better-Than-Expected COVID Sales</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Raises Annual Profit Forecast After Better-Than-Expected COVID Sales\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2024-07-30 18:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>July 30 (Reuters) - U.S. drugmaker Pfizer raised its annual profit forecast on Tuesday after posting better-than-expected sales for its COVID vaccine and antiviral treatment.</p><p>New Jersey-based Pfizer now expects annual profit to be in the range of $2.45 to $2.65 per share, compared with its prior profit forecast of $2.15 to $2.35 per share.</p><p>With the pandemic becoming less severe, the market for pharmaceutical products used in managing COVID-19 has quickly disappeared, eroding billions of dollars in sales of vaccines and treatments for companies such as Pfizer.</p><p>Pfizer said it was now expecting full-year revenue of $8.5 billion from its Comirnaty and Paxlovid vaccines, up from its previous expectation of about $8 billion.</p><p>After the company&#39;s COVID windfall, Pfizer CEO Albert Bourla spent $43 billion to buy cancer drugmaker Seagen. The company has also cut costs and launched an internal restructuring to tighten its focus on cancer drugs.</p><p>Its shares have nearly halved since their pandemic-era highs. Shares rose 3.5% at $31.6 in premarket trading.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://seekingalpha.com/news/4129958-pfizer-non-gaap-eps-of-0_60-beats-0_14-revenue-of-13_28b-beats-260m","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171080301","content_text":"July 30 (Reuters) - U.S. drugmaker Pfizer raised its annual profit forecast on Tuesday after posting better-than-expected sales for its COVID vaccine and antiviral treatment.New Jersey-based Pfizer now expects annual profit to be in the range of $2.45 to $2.65 per share, compared with its prior profit forecast of $2.15 to $2.35 per share.With the pandemic becoming less severe, the market for pharmaceutical products used in managing COVID-19 has quickly disappeared, eroding billions of dollars in sales of vaccines and treatments for companies such as Pfizer.Pfizer said it was now expecting full-year revenue of $8.5 billion from its Comirnaty and Paxlovid vaccines, up from its previous expectation of about $8 billion.After the company's COVID windfall, Pfizer CEO Albert Bourla spent $43 billion to buy cancer drugmaker Seagen. The company has also cut costs and launched an internal restructuring to tighten its focus on cancer drugs.Its shares have nearly halved since their pandemic-era highs. Shares rose 3.5% at $31.6 in premarket trading.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":4,"commentSize":1,"repostSize":1,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1171080301"}